Lorimer A R, Barbour M B, Lawrie T D
Ann Clin Res. 1983;15(1):30-4.
Eighteen patients with idiopathic hypertension were studied to assess the anti-hypertensive control, both at rest and during exercise of increasing doses of hydrochlorothiazide, metoprolol and a combination of hydrochlorothiazide and metoprolol. Each active treatment period was given for four weeks with an intervening four week placebo period, with assessments made at 2 to 4 hours and 22 to 24 hours following tablet intake. The results show that the resting systolic and diastolic values for all active treatment periods were significantly different from placebo. During exercise, the systolic blood pressure levels were significantly reduced by all active treatments with the greatest overall reduction being achieved by either metoprolol or the metoprolol-hydrochlorothiazide combination. However, the exercise induced increase in systolic blood pressure was reduced by approximately 25% by both metoprolol and the combination product, when compared to placebo, but not by the diuretic alone.
对18例特发性高血压患者进行了研究,以评估增加剂量的氢氯噻嗪、美托洛尔以及氢氯噻嗪与美托洛尔联合用药在静息状态和运动状态下的降压控制效果。每个积极治疗期为四周,中间有四周的安慰剂期,在服药后2至4小时和22至24小时进行评估。结果表明,所有积极治疗期的静息收缩压和舒张压值与安慰剂相比均有显著差异。在运动期间,所有积极治疗均使收缩压水平显著降低,其中美托洛尔或美托洛尔-氢氯噻嗪联合用药总体降压效果最佳。然而,与安慰剂相比,美托洛尔和联合用药产品均可使运动诱发的收缩压升高降低约25%,而利尿剂单独使用则无此效果。